Clinical Trial Update: Cetuximab and Bevacizumab as First-Line Therapy Followed By Combination Chemotherapy and Bevacizumab With or Without Cetuximab as Second-Line Therapy in Treating Patients With Stage IV Colorectal Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating cetuximab and bevacizumab as first-line therapy followed by chemotherapy with/without cetuximab for stage IV colorectal cancer has be…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Bevacizumab (bevacizumab)
• Cetuximab (cetuximab)

Snippet

Sponsor: Alliance for Clinical Trials in Oncology | Conditions: Colorectal Cancer | Phase 2 | Status: WITHDRAWN